OncoCyte Reported Earnings
Monday, May 12, 2025 at 4:05 PM ET
OncoCyte (OCX) reported a loss of $0.26 per share on revenue of $2.14 million for the first quarter ended March 2025. . Revenue grew 1,114.77% on a year-over-year basis.
Oncocyte is a precision diagnostics company.
Earnings Whisper Grade
Power Rating
-
-
Reported Earnings
$-0.26
Earnings Whisper®
-
Consensus Estimate
-
Earnings Surprise
Earnings Growth
Reported Revenue
$2.14 Mil
Revenue Estimate
-
Revenue Surprise
Revenue Growth